Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.
- NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_assertion description "[The discovery of activating FGFR2 mutations in endometrial carcinoma raises the possibility of employing anti-FGFR molecularly targeted therapies in patients with advanced or recurrent endometrial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.
- NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_assertion evidence source_evidence_literature NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.
- NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_assertion SIO_000772 17525745 NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.
- NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_assertion wasDerivedFrom befree-2016 NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.
- NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_assertion wasGeneratedBy ECO_0000203 NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.
- befree-2016 importedOn "2016-02-19" NP611786.RAPP18PzGHOOv8wXN06RdmWeI6wuwAiWY-lcD03sZBtE8130_provenance.